NASDAQ
Pacira BioSciences, Inc. (PCRX) has a free cash flow growth of -47.19% as of Friday, May 29, 2026. This represents a 146.13% decrease compared to its 12-month average of 102.31%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.